PTX 2.50% 4.1¢ prescient therapeutics limited

PTX Media related, page-693

  1. 7,984 Posts.
    lightbulb Created with Sketch. 3422
    Yeah I saw that... and thought to myself "Gee, didn't we hear that statement before and then waited, waited and watied some more!". I'm not phased because the wait for CellPryme-M was well worth it... and I'm confident that CP-A will be equally stellar!

    Whilst you're here, @hottod, what's you're view on the non-viral vector approach and its tie to the TFS deal? I found an insightful article on the subject of the two different types of vectors and the move towards non-viral but the challenges.

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347098/#b33

    In fact, this site is coming in more and more handy for me.

    Last edited by Shellbell: 03/09/22
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
0.001(2.50%)
Mkt cap ! $33.01M
Open High Low Value Volume
4.1¢ 4.1¢ 4.1¢ $3.305K 81.25K

Buyers (Bids)

No. Vol. Price($)
15 1355574 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 24425 1
View Market Depth
Last trade - 14.30pm 05/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.